(Q35111358)

6 August 2017

1 reference

title

Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications (English)

1 reference

6 August 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706049

26 December 2023

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(03)00041-3

26 December 2023

5

0 references

Christine Vauthier

1

object named as

Christine Vauthier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706049

26 December 2023

3

Elias Fattal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706049

Huguette Pinto-Alphandary

26 December 2023

4

object named as

Huguette Pinto-Alphandary

1 reference

6 August 2017

2

Catherine Dubernet

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

6 August 2017

25 April 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706049

full work available at URL

26 December 2023

https://api.elsevier.com/content/article/PII:S0169409X03000413?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(03)00041-3

https://api.elsevier.com/content/article/PII:S0169409X03000413?httpAccept=text/plain

26 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(03)00041-3

Advanced Drug Delivery Reviews

26 December 2023

published in

1 reference

6 August 2017

volume

55

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

519-548

1 reference

Non-adhesive cyanoacrylate as an embolic material for endovascular neurosurgery

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

A prospectus on tissue adhesives

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

The use of cyanoacrylate adhesives in peripheral embolization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Biodegradable polymeric nanoparticles as drug delivery devices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Nanocapsule technology: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Design of folic acid-conjugated nanoparticles for drug targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers: pharmacokinetics and anti-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Comparison of 2-octyl cyanoacrylate adhesive, fibrin glue, and suturing for wound closure in the porcine urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Tissue adhesive and postoperative allergic meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Closure of lacerations and incisions with octylcyanoacrylate: a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Variceal bleeding and portal hypertension: much to learn, much to explore

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Joint effects of monomer and stabilizer concentrations on physico-chemical characteristics of poly(butyl 2-cyanoacrylate) nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Vidarabine-loaded nanoparticles: a physicochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Biodegradable nanospheres containing phthalocyanines and naphthalocyanines for targeted photodynamic tumor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Labelled polycyanoacrylate nanoparticles for human in vivo use

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Improved preparation and physical studies of polybutylcyanoacrylate nanocapsules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

The Effect of Site of Administration in the Gastrointestinal Tract on the Absorption of Insulin from Nanocapsules in Diabetic Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Degradation of poly (isobutyl cyanoacrylate) nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Molecular weights of free and drug-loaded nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

In vitro model for the degradation of alkylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Degradation of poly(methyl 2-cyanoacrylates)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

In vitro heterogeneous degradation of poly(n-alkyl alpha-cyanoacrylates)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Effects of isobutyl 2-cyanoacrylate polymer on cultured cells derived from murine cerebral microvessels

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Modification of synthesis and investigation of properties for 2-cyanoacrylates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Increased bone marrow toxicity of doxorubicin bound to nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Splenic trapping of nanoparticles: complementary approaches for in situ studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Biodegradable long-circulating polymeric nanospheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Toxicity of polyalkylcyanoacrylate nanoparticles I: Free nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Toxicity and association of polycyanoacrylate nanoparticles with hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Increased cytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Evaluation of liver toxicological effects induced by polyalkylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Evaluation of hepatic antioxidant systems after intravenous administration of polymeric nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Nanocapsules: A new type of lysosomotropic carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Effect of nanoparticle-bound ampicillin on the survival of Listeria monocytogenes in mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

The uptake of ampicillin-loaded nanoparticles by murine macrophages infected with Salmonella typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Intracellular visualization of ampicillin-loaded nanoparticles in peritoneal macrophages infected in vitro with Salmonella typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Drug targeting by polyalkylcyanoacrylate nanoparticles is not efficient against persistent Salmonella

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

On the use of ion-pair chromatography to elucidate doxorubicin release mechanism from polyalkylcyanoacrylate nanoparticles at the cellular level

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Nanoparticulate systems for brain delivery of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Influence of the surfactant concentration on the body distribution of nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

The uptake and translocation of latex nanospheres and microspheres after oral administration to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Poly(alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Transmucosal delivery systems for calcitonin: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Mucoadhesive nanoparticulate systems for peptide drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Studies on the transport pathway of PBCA nanoparticles in ocular tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2803%2900041-3

7 January 2021

Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties

1

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(03)00041-3

26 December 2023

Cyanoacrylate Adhesives

4

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(03)00041-3

Expanded applications for octyl-2-cyanoacrylate as a tissue adhesive

26 December 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(03)00041-3

Comparative cell uptake of propidium iodide associated with liposomes or nanoparticles

26 December 2023

100

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(03)00041-3

Phosphorothioate antisense oligodeoxynucleotides: questions of specificity

26 December 2023

132

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(03)00041-3

26 December 2023

Identifiers

1 reference

6 August 2017

1 reference